Repligen Corp

6 nov 2026, 21:06 UTC

Repligen Corporation's shares advanced during Friday's trading session, reflecting a notable gain since Thursday's close, despite pulling back from a midday peak.

5 nov 2026, 21:04 UTC

Repligen Corporation shares fell sharply, reflecting a broader downturn in the ARK Genomic Revolution ETF, which is facing significant losses in several holdings.

4 nov 2026, 21:21 UTC

Repligen Corporation's shares declined in after-market trading, retreating from a brief peak at Wednesday's close to a notable low within its one-month trading range.

3 nov 2026, 21:07 UTC

Repligen Corporation shares are higher, supported by a rise in Revvity, Inc. following its strong third-quarter results that exceeded analyst expectations.

2 nov 2026, 21:09 UTC

Repligen Corporation shares are declining amid a broader market downturn, trading well below their 20-day moving average following an early spike that quickly reversed.

30 ott 2026, 20:03 UTC

Repligen Corporation announced a $1 billion issuance of Convertible Senior Notes due 2031, with plans to repurchase shares using $120 million of the proceeds.

29 ott 2026, 20:02 UTC

Repligen Corporation shares are advancing, remaining significantly above their 20-day moving average and near the upper end of their one-month range.

28 ott 2026, 23:03 UTC

Repligen Corporation is advancing in after-market trading, showing strong performance since Wednesday's close and trading near the upper end of its one-month range.

27 ott 2026, 20:01 UTC

Repligen Corporation reported Q3 adjusted EPS of $0.53 and revenue of $209.31 million, while narrowing FY 2026 EPS guidance amid a $38.4 million loss.

26 ott 2026, 20:07 UTC

Repligen Corp shares are higher, following an upward trend in Charles River Laboratories, which is benefiting from positive developments in its product pipeline.

23 ott 2026, 19:16 UTC

Repligen Corp shares are declining, having pulled back from earlier gains and currently trading significantly below their 20-day moving average.

22 ott 2026, 20:07 UTC

Repligen Corp shares are declining amid a broader downturn in the Life Sciences Tools & Services sector, pulling back from earlier session highs.

21 ott 2026, 20:07 UTC

Repligen Corp's shares are advancing, regaining momentum after an earlier pullback, alongside a broader market rise and notable trading activity in Charles River Laboratories.

20 ott 2026, 20:08 UTC

Repligen Corp shares are advancing, continuing a trend higher since Monday's close, despite earlier pulling back from a session high.

19 ott 2026, 19:36 UTC

Canaccord Genuity raises Repligen Corp's price target to $180.00 from $145.00 while maintaining a Hold rating, reflecting a positive reassessment of the company's value.

16 ott 2026, 22:01 UTC

Repligen Corp is trading lower in after-market hours, following a notable decline since Friday's close amid unusual volatility and positioning near its one-month range low.

15 ott 2026, 20:07 UTC

Repligen Corp shares advanced, reaching a peak before the session's conclusion.

14 ott 2026, 20:07 UTC

Repligen Corp shares are advancing, benefiting from broader market gains, despite pulling back from earlier session highs. The stock is higher since Tuesday's close.

13 ott 2026, 20:07 UTC

Repligen Corp shares are advancing as the company prepares to report its third-quarter 2026 financial results on October 27, 2026.

12 ott 2026, 21:03 UTC

Repligen Corp shares advanced during after-market hours on Monday, moving from a low return to a high return.

9 ott 2026, 20:01 UTC

Repligen Corp shares are sharply higher, continuing an upward trajectory since Thursday's close, supported by positive movement in the broader life sciences sector.

8 ott 2026, 20:07 UTC

Repligen Corp shares fell sharply, continuing a downward trend with three consecutive sessions down, despite a brief recovery earlier in the session.

7 ott 2026, 20:01 UTC

Repligen Corp. finalized its $1.5 billion acquisition of BioLife Solutions, but shares fell sharply amid ongoing declines following a prior session drop.

6 ott 2026, 21:01 UTC

Repligen Corp's shares traded modestly higher in after-market hours, marking a peak since Tuesday's close despite remaining below the 20-day moving average.

5 ott 2026, 22:15 UTC

Repligen Corp plans to acquire BioLife Solutions, contributing to a modest after-market hours gain as the stock remains above its 20-day moving average.

2 ott 2026, 20:07 UTC

Repligen Corp's shares are advancing, reflecting a broader market trend, maintaining strong performance above the 20-day moving average amid notable intraday volatility.

1 ott 2026, 20:02 UTC

Repligen Corp shares fell sharply, breaking a trend of higher daily closes and diverging from recent upward momentum.

30 set 2026, 21:01 UTC

Repligen Corp is advancing in after-market trading, reflecting broader market gains amid revised Q2 GDP growth and stronger consumer spending.

29 set 2026, 23:25 UTC

Repligen Corp has seen a modest decline in after-market trading, retracing from earlier gains and reflecting unusual volatility compared to Tuesday's close.

28 set 2026, 20:07 UTC

Repligen Corp shares are higher today, maintaining an upward trajectory since Friday's close, supported by strong performance in the life sciences sector.